Fed Sinks Markets
Health Care: Drugs
Sarepta Therapeutics Inc (SRPT: NASDAQ)
$39.78 1.63 | 4.27%
06/19/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with SRPT
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserWatch
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- User2012 picks 10/28/20121
- UserKJP Save Stockpickr Fund
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
Latest SRPT Headlines from TheStreet
- Sarepta Therapeutics Inc (SRPT): Today's Featured Health Care Winner 06.19.13 | 05:06 pm
- Stocks Tumble as Fed Stays With Bond-Buying, For Now 06.19.13 | 02:06 pm
- 5 Stocks Insiders Love Right Now 06.19.13 | 01:06 pm
- Sarepta's Eteplirsen Walk-A-Thon Now Stretches For 84 Weeks 06.19.13 | 09:06 am
- Sarepta Therapeutics Inc (SRPT): Today's Featured Health Care Winner 06.05.13 | 05:06 pm
- Sarepta Therapeutics Inc (SRPT): Today's Featured Health Care Winner 05.29.13 | 05:05 pm
- Prosensa IPO Filing Looks Good For Sarepta Therapeutics 05.28.13 | 09:05 am
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner 05.16.13 | 05:05 pm
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin 05.10.13 | 07:05 am
Press Releases for SRPT
- Over $400 Million Raised By U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings In 2012, Reports Brinson Patrick - PR Newswire 04.08.13 | 08:04 am
- Over 25 Companies To Present At Emerald Groundhog Day Investment Forum - Business Wire 02.05.13 | 10:02 am
Partner Headlines for SRPT
- What Must Be In The Ideal Biopharmaceutical Portfolio? - Seeking Alpha 06.05.13 | 09:06 am
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In - Seeking Alpha 04.11.13 | 09:04 am
- Barron's Recap (3/23/13): World's Best CEOs - Benzinga 03.24.13 | 01:03 pm
- Sarepta Therapeutics Setting Up For Another Move Upward - Seeking Alpha 01.31.13 | 09:01 am
- Raptor To Rise On Proven Strategy & Upcoming FDA Decision - Seeking Alpha 12.28.12 | 09:12 am
- UPDATE: Burril Initiates Sarepta Therapeutics at Market Outperform on Eteplirsen Potential - Benzinga 11.26.12 | 09:11 am
- Sarepta Therapeutics to Present Additional 48-Week Data From the Phase IIb Study of Eteplirsen for Treatment of Duchenne Muscular Dystrophy - Benzinga 10.12.12 | 04:10 pm
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
- Benzinga Mid-Morning Market Update - Benzinga 10.05.12 | 01:10 pm
